Search

Your search keyword '"Laufs, U"' showing total 63 results

Search Constraints

Start Over You searched for: Author "Laufs, U" Remove constraint Author: "Laufs, U" Database OAIster Remove constraint Database: OAIster
63 results on '"Laufs, U"'

Search Results

1. Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study.

2. Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy.

3. Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy.

4. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials.

5. Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021.

6. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia.

7. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia.

8. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

11. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe:methodology and rationale for the multinational observational SANTORINI study

12. Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial.

13. Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial.

14. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.

15. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.

16. Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany.

17. Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany.

18. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.

21. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.

22. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.

23. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.

24. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

25. Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure.

26. Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure.

27. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk.

28. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial.

29. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial.

30. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk.

31. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study.

32. In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

33. In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

34. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study.

35. Comments on the guidelines of the European Society of Cardiology (ESC) on the diagnostics and treatment of acute and chronic heart failure

36. Comments on the guidelines of the European Society of Cardiology (ESC) on the diagnostics and treatment of acute and chronic heart failure

37. Do patients with diabetes type 2 or chronic heart failure understand a medication plan?

38. Do patients with diabetes type 2 or chronic heart failure understand a medication plan?

39. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

42. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.

43. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.

44. Medication knowledge of patients hospitalized for heart failure at admission and after discharge.

45. Evaluating patients' comprehensibility of a standardized medication plan.

46. Medication knowledge of patients hospitalized for heart failure at admission and after discharge.

47. Evaluating patients' comprehensibility of a standardized medication plan.

48. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

49. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension

50. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk

Catalog

Books, media, physical & digital resources